Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Over-the-counter cosmetic creams can cause skin damage on the face that is visible under dermoscopy and confirmed by tissue analysis.

Temporal hair loss relates to overall scalp hair loss in women.

Washing test helps identify hair loss type, low iron levels significant.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Tofacitinib is an effective and safe treatment for alopecia areata.

Melanoma characteristics vary by age, which could help doctors with diagnosis and prevention.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

IL-17 and certain immune cells are linked to more severe alopecia areata.

The study concluded that there is no significant link between thyroid autoimmunity and alopecia areata.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Scalp melanoma is more common and easier to diagnose early in people with androgenetic alopecia due to sun damage.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

The technique accurately identifies and evaluates hair follicle structures in skin.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Leflunomide is more likely to help treat alopecia areata than cause it.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Zinc oxide nanoparticle biscuits improved growth and health in zinc-deficient rats without toxicity.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.